Gilead's Mansuri Joins Sanofi
This article was originally published in Scrip
Sanofi has appointed Muzammil Mansuri member of the executive committee and executive vice president, strategy and business development. Mansuri joins Sanofi from Gilead Sciences where he most recently was senior vice president, research and development strategy and corporate development. He brings over 35 years' experience to the company and started out as a research scientist at Shell Research Ltd. Previously he held various R&D roles in Bristol-Myers Company and was chair and CEO at CGI Pharmaceuticals.